The Risk of Venous Thromboembolism Associated with the Factor V Leiden Mutation and Low B-Vitamin Status

Verfasser / Beitragende:
[Rima Obeid, Tarek Hakki, Muhidien Jouma, Wolfgang Herrmann]
Ort, Verlag, Jahr:
2003
Enthalten in:
Clinical Chemistry and Laboratory Medicine, 41/10(2003-09-19), 1357-1362
Format:
Artikel (online)
ID: 37884945X
LEADER caa a22 4500
001 37884945X
003 CHVBK
005 20180305123320.0
007 cr unu---uuuuu
008 161128e20030919xx s 000 0 eng
024 7 0 |a 10.1515/CCLM.2003.208  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1515/CCLM.2003.208 
245 0 4 |a The Risk of Venous Thromboembolism Associated with the Factor V Leiden Mutation and Low B-Vitamin Status  |h [Elektronische Daten]  |c [Rima Obeid, Tarek Hakki, Muhidien Jouma, Wolfgang Herrmann] 
520 3 |a Venous thromboembolism (VTE) is a multi-factorial disease involving numerous genetic and environmental risk factors. In this study we investigated the occurrence and the risk associated with factor V Leiden, hyperhomocysteinemia and low folate and vitamin B12 levels in young patients with thrombosis. We studied 78 patients (33 females/45 males, mean age 33 years) with a history of thrombosis in a lower limb. Additionally, 98 healthy subjects (45 females/54 males, mean age 44 years) were included. Serum levels of homocysteine (Hcy), folate and vitamin B12 were assayed. Factor V Leiden and methylenetetrahydrofolate reductase (MTHFR) C677T mutations were investigated in all subjects. Factor V Leiden was highly prevalent in the patients (39% heterozygous, 10% homozygous vs. 6.3% heterozygous in controls). An increase in the risk of idiopathic VTE was associated with Hcy levels >15.2 µmol/l (odds ratio, OR = 2.83), folate <15.1 nmol/l (OR = 7.49) and vitamin B12 <182 pmol/l (OR = 11.97). Low levels of folate or vitamin B12 were independently and strongly associated with the risk of VTE in a multivariate model (OR for idiopathic thrombosis = 16.44 and 10.76, respectively). Twenty patients (53%), carriers of factor V Leiden, had low levels of vitamin B12, compared to 28% of patients who were noncarriers of the mutation (p = 0.03). In contrast, none of the control carriers of the mutation had a low level of vitamin B12. The risk of VTE associated with lower levels of vitamin B12 and folate was stronger than that introduced by elevated Hcy levels. The increased risk of VTE, accompanied by factor V Leiden, may be related to confounding environmental factors. Clin Chem Lab Med 2003; 41(10):13571362 
540 |a Copyright © 2003 by Walter de Gruyter GmbH & Co. KG 
690 7 |a Medical equipment & techniques  |2 nationallicence 
690 7 |a Medical diagnosis  |2 nationallicence 
690 7 |a Diseases & disorders  |2 nationallicence 
700 1 |a Obeid  |D Rima  |4 aut 
700 1 |a Hakki  |D Tarek  |4 aut 
700 1 |a Jouma  |D Muhidien  |4 aut 
700 1 |a Herrmann  |D Wolfgang  |4 aut 
773 0 |t Clinical Chemistry and Laboratory Medicine  |d Walter de Gruyter  |g 41/10(2003-09-19), 1357-1362  |x 1434-6621  |q 41:10<1357  |1 2003  |2 41  |o cclm 
856 4 0 |u https://doi.org/10.1515/CCLM.2003.208  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1515/CCLM.2003.208  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Obeid  |D Rima  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Hakki  |D Tarek  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Jouma  |D Muhidien  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Herrmann  |D Wolfgang  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Clinical Chemistry and Laboratory Medicine  |d Walter de Gruyter  |g 41/10(2003-09-19), 1357-1362  |x 1434-6621  |q 41:10<1357  |1 2003  |2 41  |o cclm 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter